Sarah M. Nielsen

3.1k total citations
75 papers, 882 citations indexed

About

Sarah M. Nielsen is a scholar working on Genetics, Cancer Research and Oncology. According to data from OpenAlex, Sarah M. Nielsen has authored 75 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Genetics, 23 papers in Cancer Research and 19 papers in Oncology. Recurrent topics in Sarah M. Nielsen's work include BRCA gene mutations in cancer (41 papers), Cancer Genomics and Diagnostics (17 papers) and Genetic factors in colorectal cancer (14 papers). Sarah M. Nielsen is often cited by papers focused on BRCA gene mutations in cancer (41 papers), Cancer Genomics and Diagnostics (17 papers) and Genetic factors in colorectal cancer (14 papers). Sarah M. Nielsen collaborates with scholars based in United States, Jordan and Australia. Sarah M. Nielsen's co-authors include Edward D. Esplin, Olufunmilayo I. Olopade, Robert L. Nussbaum, Charis Eng, Kathryn E. Hatchell, Sharaf Karim Perdawood, Raymon H. Grogan, Lindsay Rhodes, Richard J. Kahnoski and Eamonn R. Maher and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Sarah M. Nielsen

65 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah M. Nielsen United States	16	340	329	273	255	147	75	882
Lisa Golmard France	17	139 0.4×	362 1.1×	231 0.8×	345 1.4×	218 1.5×	51	873
Hongzhou Cai China	18	493 1.4×	149 0.5×	203 0.7×	610 2.4×	235 1.6×	44	1.0k
Morihiko Kimura Japan	16	204 0.6×	145 0.4×	349 1.3×	191 0.7×	94 0.6×	47	698
A. Michael Bilous Australia	15	349 1.0×	224 0.7×	332 1.2×	384 1.5×	384 2.6×	30	960
Jill Hagenkord United States	19	336 1.0×	168 0.5×	216 0.8×	380 1.5×	293 2.0×	32	985
Kasmintan A. Schrader Canada	19	341 1.0×	597 1.8×	306 1.1×	465 1.8×	257 1.7×	75	1.4k
Ciara C. O’Sullivan United States	18	299 0.9×	98 0.3×	590 2.2×	293 1.1×	262 1.8×	72	1.0k
Takaomi Suzuma Japan	17	256 0.8×	185 0.6×	306 1.1×	358 1.4×	148 1.0×	52	885
S. Johnston United Kingdom	18	262 0.8×	371 1.1×	508 1.9×	265 1.0×	212 1.4×	50	923
Thomas P. Slavin United States	16	404 1.2×	262 0.8×	255 0.9×	387 1.5×	166 1.1×	44	917

Countries citing papers authored by Sarah M. Nielsen

Since Specialization

Citations

This map shows the geographic impact of Sarah M. Nielsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah M. Nielsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah M. Nielsen more than expected).

Fields of papers citing papers by Sarah M. Nielsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah M. Nielsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah M. Nielsen. The network helps show where Sarah M. Nielsen may publish in the future.

Co-authorship network of co-authors of Sarah M. Nielsen

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah M. Nielsen. A scholar is included among the top collaborators of Sarah M. Nielsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah M. Nielsen. Sarah M. Nielsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kanayama, Mayuko, Émeline Colomba, Sarah M. Nielsen, et al.. (2025). Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variant. Prostate Cancer and Prostatic Diseases.

Lerner, Benjamin A., Marcy E. Richardson, Lisa R. Susswein, et al.. (2024). Validation of the NCCN/Yale criteria for the identification of CDH1 pathogenic variant carriers. Journal of Medical Genetics. 62(2). 57–61.

Nielsen, Sarah M., Elaine Chen, Brandie Heald, et al.. (2024). Disparate Rates of Germline Variants in Cancer Predisposition Genes in African American/Black Compared With Non-Hispanic White Individuals Between 2015 and 2022. JCO Precision Oncology. 8(8). e2300715–e2300715. 2 indexed citations

Warren, Christopher J., Katie L. Kunze, Michael A. Golafshar, et al.. (2024). Germline Pathogenic Variants Identified in Patients With Genitourinary Malignancies Undergoing Universal Testing: A Multisite Single-Institution Prospective Study. The Journal of Urology. 212(4). 590–599. 1 indexed citations

Abdel‐Razeq, Hikmat, Abdelghani Tbakhi, Rachel E. Ellsworth, et al.. (2024). Implementation of Universal Pan-Cancer Germline Genetic Testing in an Arab Population: The Jordanian Exploratory Cancer Genetics Study. JCO Global Oncology. 10(10). e2400068–e2400068. 1 indexed citations

Nielsen, Sarah M., et al.. (2024). Patterns and Frequency of Pathogenic Germline Variants Among Prostate Cancer Patients Utilizing Multi-Gene Panel Genetic Testing. World Journal of Oncology. 15(5). 801–808.

Paul, Christine, Nicole M. Verrills, Stephen P. Ackland, et al.. (2024). The impact of a regionally based translational cancer research collaborative in Australia using the FAIT methodology. BMC Health Services Research. 24(1). 320–320.

Funchain, Pauline, Ying Ni, Brandie Heald, et al.. (2024). Germline cancer susceptibility in individuals with melanoma. Journal of the American Academy of Dermatology. 91(2). 265–272. 8 indexed citations

Sonpavde, Guru, et al.. (2023). Germline genetic testing of patients with penile carcinoma.. Journal of Clinical Oncology. 41(6_suppl). 10–10. 1 indexed citations

10.

Kanayama, Mayuko, Yidong Chen, Changxue Lu, et al.. (2023). Clinical and Functional Analyses of an African-ancestry Gain-of-function HOXB13 Variant Implicated in Aggressive Prostate Cancer. European Urology Oncology. 7(4). 751–759. 5 indexed citations

11.

Heald, Brandie, Sara Pirzadeh‐Miller, Rachel E. Ellsworth, et al.. (2023). Cascade testing for hereditary cancer: comprehensive multigene panels identify unexpected actionable findings in relatives. JNCI Journal of the National Cancer Institute. 116(2). 334–337. 3 indexed citations

12.

Althouse, Sandra K., Patrick O. Monahan, Lisa Hayes, et al.. (2023). Racial disparities in cascade testing for cancer predisposition genes. Preventive Medicine. 172. 107539–107539. 9 indexed citations

13.

Adib, Elio, Talal El Zarif, Amin H. Nassar, et al.. (2021). CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer. British Journal of Cancer. 126(5). 797–803. 18 indexed citations

14.

Lu, Eric, Kathryn E. Hatchell, Sarah M. Nielsen, et al.. (2021). Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing. Cancer. 128(4). 675–684. 16 indexed citations

15.

Nielsen, Sarah M., et al.. (2020). Anastomotic technique is not associated with leakage rate after right hemicolectomy.. PubMed. 67(9). 3 indexed citations

16.

Hedeker, Donald, Sarah M. Nielsen, Mary B. Daly, et al.. (2019). Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study. Cancer Medicine. 8(12). 5609–5618. 7 indexed citations

17.

Nielsen, Sarah M., Arcangela De Nicolo, Diana Eccles, et al.. (2018). Genetic testing and clinical management practices for variants in non-BRCA1/2 breast (and/or ovarian) cancer susceptibility genes: An international survey by the Enigma Clinical Working Group.. Journal of Clinical Oncology. 36(15_suppl). 1539–1539. 5 indexed citations

18.

Nielsen, Sarah M.. (2013). “Half Bricks and Half Clicks”: Is Blended Onsite and Online Teaching and Learning the Best of Both Worlds?. Florida International University Digital Commons (Florida International University). 3 indexed citations

19.

Nielsen, Sarah M., Wendy S. Rubinstein, Darcy L. Thull, et al.. (2011). Long-term outcomes, branch-specific expressivity, and disease-related mortality in von Hippel-Lindau type 2A. Familial Cancer. 10(4). 701–707. 2 indexed citations

20.

Nielsen, Sarah M., Wendy S. Rubinstein, Darcy L. Thull, et al.. (2010). Genotype–phenotype correlations of pheochromocytoma in two large von Hippel–Lindau (VHL) type 2A kindreds with different missense mutations. American Journal of Medical Genetics Part A. 155(1). 168–173. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact